NCT00000865View on ClinicalTrials.gov

The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Study Completion Date

April 30, 1998

Conditions

HIV Infections

Interventions

DRUG

Abacavir sulfate

DRUG

Lamivudine

DRUG

Stavudine

DRUG

Zidovudine

DRUG

Didanosine

Trial Locations (7)

10457

Bronx-Lebanon Hosp. IMPAACT CRS, The Bronx

77030

Texas Children's Hosp. CRS, Houston

90033

Usc La Nichd Crs, Los Angeles

277103499

DUMC Ped. CRS, Durham

381052794

St. Jude/UTHSC CRS, Memphis

701122699

Tulane/LSU Maternal/Child CRS, New Orleans

920930672

UCSD Maternal, Child, and Adolescent HIV CRS, San Diego

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000865 - The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children | Biotech Hunter | Biotech Hunter